Beauchamp MC - Search Results

1

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.

Amin O, Beauchamp MC, Nader PA, Laskov I, Iqbal S, Philip CA, Yasmeen A, Gotlieb WH. Amin O, et al. Among authors: beauchamp mc. BMC Cancer. 2015 Oct 29;15:817. doi: 10.1186/s12885-015-1803-y. BMC Cancer. 2015. PMID: 26510816 Free PMC article.

2

BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.

Beauchamp MC, Knafo A, Yasmeen A, Carboni JM, Gottardis MM, Pollak MN, Gotlieb WH. Beauchamp MC, et al. Gynecol Oncol. 2009 Nov;115(2):193-8. doi: 10.1016/j.ygyno.2009.07.009. Epub 2009 Aug 21. Gynecol Oncol. 2009. PMID: 19699512

3

Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors.

Marques M, Beauchamp MC, Fleury H, Laskov I, Qiang S, Pelmus M, Provencher D, Mes-Masson AM, Gotlieb WH, Witcher M. Marques M, et al. Among authors: beauchamp mc. BMC Med. 2015 Sep 9;13:217. doi: 10.1186/s12916-015-0454-9. BMC Med. 2015. PMID: 26354718 Free PMC article.

4

Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.

Laskov I, Abou-Nader P, Amin O, Philip CA, Beauchamp MC, Yasmeen A, Gotlieb WH. Laskov I, et al. Among authors: beauchamp mc. Int J Gynecol Cancer. 2016 Sep;26(7):1213-21. doi: 10.1097/IGC.0000000000000761. Int J Gynecol Cancer. 2016. PMID: 27643646

5

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.

Philip CA, Laskov I, Beauchamp MC, Marques M, Amin O, Bitharas J, Kessous R, Kogan L, Baloch T, Gotlieb WH, Yasmeen A. Philip CA, et al. Among authors: beauchamp mc. BMC Cancer. 2017 Sep 8;17(1):638. doi: 10.1186/s12885-017-3639-0. BMC Cancer. 2017. PMID: 28886696 Free PMC article.

6

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, Pollak MN, Bruchim I. Gotlieb WH, et al. Among authors: beauchamp mc. Gynecol Oncol. 2008 Aug;110(2):246-50. doi: 10.1016/j.ygyno.2008.04.008. Epub 2008 May 21. Gynecol Oncol. 2008. PMID: 18495226

7

Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer.

Beauchamp MC, Yasmeen A, Knafo A, Gotlieb WH. Beauchamp MC, et al. J Oncol. 2010;2010:257058. doi: 10.1155/2010/257058. Epub 2010 Jan 5. J Oncol. 2010. PMID: 20069126 Free PMC article.

8

Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins.

Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M, Gotlieb WH. Yasmeen A, et al. Among authors: beauchamp mc. Gynecol Oncol. 2011 Jun 1;121(3):492-8. doi: 10.1016/j.ygyno.2011.02.021. Epub 2011 Mar 8. Gynecol Oncol. 2011. PMID: 21388661

9

Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.

Segal ED, Yasmeen A, Beauchamp MC, Rosenblatt J, Pollak M, Gotlieb WH. Segal ED, et al. Among authors: beauchamp mc. Biochem Biophys Res Commun. 2011 Nov 4;414(4):694-9. doi: 10.1016/j.bbrc.2011.09.134. Epub 2011 Oct 2. Biochem Biophys Res Commun. 2011. PMID: 21986525

10

Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.

Laskov I, Drudi L, Beauchamp MC, Yasmeen A, Ferenczy A, Pollak M, Gotlieb WH. Laskov I, et al. Among authors: beauchamp mc. Gynecol Oncol. 2014 Sep;134(3):607-14. doi: 10.1016/j.ygyno.2014.06.014. Epub 2014 Jun 24. Gynecol Oncol. 2014. PMID: 24972190 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters